Tuğba Songül TAT, Mustafa YILMAZ, AHMET ALVER, Gülşah BAYÇELEBİ

ERİŞKİN İDİYOPATİK TROMBOSİTOPENİK PURPURALI HASTALARDA IL-10 VE IL-17 GEN POLİMORFİZMİ

Amaç: İnterlökin 10 (IL-10) ve interlökin 17 (IL-17) sitokin gen polimorfizmlerinin otoimmün birçok hastalıkta araştırıldığı ve bazılarında anlamlı sonuçlar bulunduğu, ancak idiyopatik trombositopenik purpuralı (ITP) hastalarda IL-10 ve IL-17 gen polimorfizmleri ile ilgili yayınlanmış az sayıda çalışma olduğu görülmüştür. Bu çalışmada erişkin ITP hastalarında IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmi ve bu sitokinlerin serum düzeylerinin değerlendirilmesi amaçlanmıştır. Materyal ve Metot: 50 ITP’ li hasta ve 51 sağlıklı kontrol grubunda IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmleri, DNA izolasyonu yapıldıktan sonra belirlenmiş ve bu sitokinlerin serum düzeyleri ELİSA yöntemi ile aynı hasta grubunda toplam 32 hastada ve 32 sağlıklı kişide ölçülmüştür. Bulgular: Hasta ve kontrol grupları arasında IL-10 (-592 A/C) ve IL17 (A126G) gen polimorfizmleri dağılımı açısından istatistiksel olarak anlamlı fark bulunmazken, serum IL-10 düzeyleri ITP’li hastalarda sağlıklı bireylere göre istatistiksel olarak anlamlı derecede yüksek bulunmuştur (p=0,003). Serum IL-17 düzeyleri ise hasta ve kontrol grubunda benzer bulunmuştur. Ayrıca gruplar arasında yaş, cinsiyet, tedavi cevabı, tanı anındaki trombosit değerleri karşılaştırılmış ancak gruplar arasında istatistiksel olarak anlamlı fark saptanmamıştır. Sonuç: Çalışmamızda ITP’li hastalarda sağlıklı kişilere göre IL-10 (- 592 A/C) ve IL-17 (A126G) gen polimorfizmleri sıklıklarının farklı olduğu saptanmamış ancak IL-10 düzeyleri ITP’li grupta yüksek bulunmuştur. Sitokinlerin ITP’nin tanı ve takibindeki önemini açıklığa kavuşturabilmek için literatürdeki veriler de dikkate alındığında bu alanda daha geniş hasta içeren çalışmalara ihtiyaç olduğunu düşünmekteyiz.

IL-10 AND IL-17 GENE POLYMORPHİSMS IN ADULT IDIOPATHIC THROMBOCYTOPENIC PURPURA

Aim: Interleukin 10 (IL-10) and interleukin 17 (il-17) cytokine gene polymorphisms were investigated in many autoimmune diseases and there were significant results in some studies but a few published studies on IL-10 and il-17 gene polymorphisms in idiopathic thrombocytopenic purpura (ITP) were seen in the literature. In this study, we aimed to evaluate the IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms and their serum levels in adult patients with ITP. Materials and Methods: The IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms in 50 patients with ITP and 51 healthy control groups were determined after DNA isolation and serum levels of these cytokines were measured by ELISA method, in 32 patients with ITP in the same group and 32 healthy volunteers. Results: There was no statistically significant difference in IL-10 (- 592 A/C) and IL-17 (A126G) gene polymorphisms between the patients and control groups, whereas serum IL-10 levels were found to be statistically significant higher in ITP patients than control group (p=0.003). Serum IL-17 levels were similar in patients and control groups. In addition, age, sex, response to treatment and platelet values at diagnosis were compared between the groups, but there was no statistically significant difference. Conclusion: In our study, IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms were not found to be different in patients with ITP compared to healthy subjects, although IL-10 levels were found to be higher in the ITP group than healthy group. When we look the datas in the literature, we thought that more studies with larger series are needed in this field in order to clarify the importance of cytokines in the diagnosis and follow-up of ITP.

PDF

___

Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829–35.
Semple JW, Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take centerstage Curr Opinion Hematol. 2012;19(5):357-62
Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5-17.
Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 2005;90(7):914-23.
Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1/ Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2003;71(4):283-8.
Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, et al. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica. 2011;96(10):1560- 4.
ZhouL, XuF, ChangC, TaoY, SongL, LiX. Interleukin17-producing CD4+T lymphocytes are increased in the patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2016;27(3):301-7.
Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18.
Zhang G, Zhang P, Liu H, Liu X, Xie S, Wang X, et al. Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model. Hematology. 2017;22(8):493-500.
Rezaeeyan H, Jaseb K, Alghasi A, Asnafi AA, Saki N. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis. 2017;28(8):617- 22.
Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T, et al. Investigation of TNF-alpha, TGFbeta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22(8):588- 95.
Saitoh T, Kasamatsu T, Inoue M, Mitsui T, Koiso H, Yokohama A, et al. Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. Int J Lab Hematol. 2011;33(5):526-32.
Wu KH, Peng CT, Li TC, Wan L, Tsai CH, Lan SJ, Chang MC, Tsai FJ. Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. Br J Haematol. 2005;128(6):849-52.
Khalilzadeh O, Anvari M, Momen-Heravi F, Esteghamati A, Rashidi A, Mahmoudi M, et al. Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves’ disease. Clin Exp Med. 2010;10(2):123–8.
Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int. 2010;30(9):1211–7.
Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, et al. Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int. 2008;29(2):173-8.
Ma D, Zhu X, Zhao P, Zhao C, Li X, Zhu Y, et al. Profile of Th17 cytokines (IL-17, TGFbeta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 2008;87(11):899-904.
Ji L, Zhan Y, Hua F, Li F, Zou S, Wang W, et al. The ratio of treg/th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS One. 2012;7(12): e50909.
Hu Y, Ma DX, Shan NN, Zhu YY, Liu XG, Zhang L, et al. Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One. 2011;6(10): e26522.
Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94(9):1326-9.
Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015; 61:269-80.
Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, et al. Abnormality of CD4(+) CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol. 2007;78(2):139-43.
Tesse R, Del Vecchio GC, De Mattia D, Sangerardi M, Valente F, Giordano P. Association of interleukin- (IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. Gene. 2012;505(1):53-6.
Saitoh T, Tsukamoto N, Koiso H, Mitsui T, Yokohama A, Handa H, et al. Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia. Eur J Haematol. 2011;87(3);253-8.
Culic S, Labar B, Marusic A, Salamunic I. Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47(5):671-4.
Wang JD, Chang TK, Lin HK, Huang FL, Wang CJ, Lee HJ. Reduced expression of transforming growth factor‐β1 and correlated elevation of interleukin‐17 and interferon‐γ in pediatric patients with chronic primary immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2011;57(4):636-40.
Guo NH, Shi QZ, Hua JY, Li ZJ, Li J, He WF, et al. Expression of regulatory T cells and Th17 cells in idiopathic thrombocytopenic purpura and its significance. Zhonghua Xue Ye Xue Za Zhi. 2010;31(9):610-12.
Chang DY, Ouyang J, Zhou RF, Xu JY, Chen B, Yang YG, et al. Profiles of different subsets of CD (4) (+) T cells in chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi. 2010;49(3):213-6.
Wang X, Zhou YH, Chen XH, Yin LM, Zhao YN, Wo, LK, et al. Role and Significance of T Help Cells 17 in Pathogenesis of Idiopathic Thrombocytopenic Purpura. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(6):1833-36.
Qiao J, Li X, Wu Y, Wu X, Zhu F, Liu N, et al. An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia. Platelets. 2017;28(3);287-94.
Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, et al. IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol. 2007;68(2):122-7.
Abanmi A, Al HF, Zouman A, Kudwah A, Jamal MA, Arfin M, et al. Association of Interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis Markers. 2008;24(1):51-7.
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y. et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9.
Paradowska‐Gorycka A, Wojtecka‐Lukasik E, Trefle J, Wojciechowska B, Lacki JK, Maslinski S. Association between IL‐17F Gene Polymorphisms and Susceptibility to and Severity of Rheumatoid Arthritis (RA). Scand J Immunol.2010;72(2):134-41.